This cell line can be used as a control alongside LRRK2 KO RAW 264.7 (ATCC® SC‐6004TM) or LRRK2 T1348N mut RAW 264.7 (ATCC® SC‐6005TM) in experiments determining the role of LRRK2 in Parkinson's disease. This evidence concerns the gene LRRK2 and Parkinson disease.